Healthcare IT News August 27, 2024
For the price tag, McKesson will have a controlling interest representing about 70% ownership of Core Ventures.
Healthcare services company McKesson has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures (Core Ventures) for about $2.49 billion.
Core Ventures, a business and administrative services organization, was established by Florida Cancer Specialists and Research Institute, a physician-owned community oncology practice. FCS physicians will continue to retain a minority interest in Core Ventures.
For the price tag, McKesson will have a controlling interest representing about 70% ownership. Following completion of the transaction, Core Ventures will be part of the Oncology platform, and financial results will be reported within McKesson’s U.S. Pharmaceutical segment.
WHAT’S THE IMPACT
Following...
Today's Sponsors
Today's Sponsor